Current concepts of redox signaling in the lungs

Antioxidants and Redox Signaling

Volumn 8, Issue 3-4, 2006, Pages 681-689

  Rahman, Irfan ^a   Yang, Se Ran ^a   Biswas, Saibal K ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Dr Ambedkar College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; ANTIOXIDANT; APOPTOSIS SIGNAL REGULATING KINASE 1; CURCUMIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYSTEINE; CYTOKINE; GLUTATHIONE; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONTELUKAST; MRS 2481; PHOSPHOTRANSFERASE; POLYPHENOL; PYRIDINIUM DERIVATIVE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RITUXIMAB; ROFLUMILAST; SULFENIC ACID DERIVATIVE; SULFINIC ACID DERIVATIVE; SULFONIC ACID DERIVATIVE; THIOL DERIVATIVE; THIOREDOXIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; CYSTIC FIBROSIS; DIETARY INTAKE; DRUG EFFECT; DRUG POTENCY; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG DISEASE; NITROSATION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTECTION; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; CYTOKINES; GLUTATHIONE; HUMANS; INFLAMMATION; LUNG; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; THIOREDOXIN;

EID: 33646698196     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.8.681     Document Type: Short Survey

References (89)

1. Abate C, Patel L, Rauscher FJ, 3rd, and Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249: 1157-1161, 1990.
2. Adcock IM, Cosio B, Tsaprouni L, Barnes PJ, and Ito K. Redox regulation of histone deacetylases and glucocorticoid-mediated inhibition of the inflammatory response. Antioxid Redox Signal 7: 144-152, 2005.
3. Ballinger CA, Cueto R, Squadrito G, Coffin JF, Velsor LW, Pryor WA, and Postlethwait EM. Antioxidant-mediated augmentation of ozone-induced membrane oxidation. Free Radic Biol Med 38: 515-526, 2005.
4. Banning A, Deubel S, Kluth D, Zhou Z, and Brigelius-Flohe R. The GI-GPx gene is a target for NrG. Mol Cell Biol 25: 4914-4923, 2005.
5. Biswas SK, McClure D, Jimenez LA, Megson IL, and Rahman I. Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar, epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signal 7: 32-41, 2005.
6. 6: Borra MT, Smith BC, and Denu JM. Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 280: 17187-17195, 2005.
7. Bundy RE, Hoare GS, Kite A, Beach J, Yacoub M, and Marczin N. Redox regulation of p38 MAPK activation and expression of ICAM-1 and heme oxygenase-1 in human alveolar epithelial (A549) cells. Antioxid Redox Signal 7: 14-24, 2005.
8. Burke-Gaffney A, Callister ME, and Nakamura H. Thioredoxin: friend or foe in human disease? Trends Pharmacol Sci 26: 398-404, 2005.
9. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med 9: 161-168, 2003.
10. Chauveau C, Remy S, Royer PJ, Hill M, Tanguy-Royer S, Hubert FX, Tesson L, Brion R, Beriou G, Gregoire M, Josien R, Cuturi MC, and Anegon I. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 106: 1694-1702, 2005.
11. Chu SC, Marks-Konczalik J, Wu HP, Banks TC, and Moss J. Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem Biophys Res Commun 248: 871-878, 1998.
12. Claiborne A, Yeh JI, Mallett TC, Luba J, Crane EJ, 3rd, Charrier V, and Parsonage D. Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation. Biochemistry 38: 15407-15416, 1999.
13. Comhair SA and Erzurum SC. The regulation and role of extracellular glutathione peroxidase. Antioxid Redox Signal 7: 72-79, 2005.
14. Cooke RW and Drury JA. Reduction of oxidative stress marker in lung fluid of preterm infants after administration of intra-tracheal liposomal glutathione. Biol Neonate 87: 178-180, 2005.
15. 2 receptor and redoxtransducer in gene activation. Cell 111: 471-481, 2002.
16. Di Simplicio P, Franconi F, Frosali S, and Di Giuseppe D. Thiolation and nitrosation of cysteines in biological fluids and cells. Amino Acids 25: 323-339, 2003.
17. Dimmeler S, Lottspeich F, and Brune B. Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 267: 16771-16774, 1992.
18. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, and Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 99: 11908-11913, 2002.
19. Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, Dicato M, and Diederich M. Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223: 181-190, 2005.
20. Ferrari F, Mennuni L, Caselli G, Zanelli T, and Makovec F. Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activity. Eur J Pharmacol 504: 223-233, 2004.
21. Filomeni G, Rotilio G, and Ciriolo MR. Glutathione disulfide induces apoptosis in U937 cells by a redox-mediated p38 MAP kinase pathway. FASEB J 17: 64-66, 2003.
22. Finkelstein EI, Ruben J, Koot CW, Hristova M, and van der Vliet A. Regulation of constitutive neutrophil apoptosis by the {alpha},{beta}- unsaturated aldehydes acrolein and 4-hydroxynonenal. Am J Physiol Lung Cell Mol Physiol 289: L1019-L1028, 2005.
23. Goldkorn T, Ravid T, and Khan EM. Life and death decisions: ceramide generation and EGF receptor trafficking are modulated by oxidative stress. Antioxid Redox Signal 7: 119-128, 2005.
24. Hancock JF, Magee AI, Childs JE, and Marshall CJ. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57: 1167-1177, 1989.
25. Hansen JM, Go YM, and Jones DP. Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling. Annu Rev Pharmacol Toxicol Sep 7, 2005. [Epub ahead of print].
26. Henderson WR, Jr., Chi EY, Teo JL, Nguyen C, and Kahn M. A small molecule inhibitor of redox-regulated NF-kappa B and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model. J Immunol 169: 5294-5299, 2002.
27. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, and Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA 94: 3633-3638, 1997.
28. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, and Sinclair DA. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-196, 2003.
29. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, and Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-94, 1997.
30. Iles KE and Liu RM. Mechanisms of glutamate cysteine ligase (GCL) induction by 4-hydroxynonenal. Free Radic Biol Med 38: 547-556, 2005.
31. Immenschuh S and Baumgart-Vogt E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal 7: 768-777, 2005.
32. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC, and Barnes PJ. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352: 1967-1976, 2005.
33. Jin SL, Lan L, Zoudilova M, and Conti M. Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages. J Immunol 175: 1523-1531, 2005.
34. Kabe Y, Ando K, Hirao S, Yoshida M, and Handa H. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 7: 395-403, 2005.
35. Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, Caldwell SD, Napper A, Curtis R, DiStefano PS, Fields S, Bedalov A, and Kennedy BK. Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 280: 17038-17045, 2005.
36. Kiaei M, Kipiani K, Chen J, Calingasan NY, and Beal MF. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis. Exp Neurol 191: 331-336, 2005.
37. Kim YA, Lee WH, Choi TH, Rhee SH, Park KY, and Choi YH. Involvement of p2 IWAF1/CIP1, pRB, Bax, and NF-kappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells. Int J Oncol 23: 1143-1149, 2003.
38. Kinnula VL, Fattman CL, Tan RJ, and Oury TD. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med 172: 417-422, 2005.
39. Kobayashi M and Yamamoto M. Molecular mechanisms activating the Nrf2-Keapl pathway of antioxidant gene regulation. Antioxid Redox Signal 7: 385-394, 2005.
40. Kumar A, Kingdon E, and Norman J. The isoprostane 8-iso-PGF2alpha suppresses monocyte adhesion to human microvascular endothelial cells via two independent mechanisms. FASEB J 19: 443-445, 2005.
41. Kundu JK and Surh YJ. Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1as potential targets. Mutat Res 555: 65-80, 2004.
42. Kwak HJ, Song JS, Heo JY, Yang SD, Nam JY, and Cheon HG. Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of NF-{kappa}B, P38 MAP kinase and JNK activation. J Pharmacol Exp Ther 315: 1188-1195, 2005.
43. Land SC and Wilson SM. Redox regulation of lung development and perinatal lung epithelial function. Antioxid Redox Signal 7: 92-107, 2005.
44. Lautier D, Luscher P, and Tyrrell RM. Endogenous glutathione levels modulate both constitutive and UVA radiation/hydrogen peroxide inducible expression of the human heme oxygenase gene. Carcinogenesis 13: 227-232, 1992.
45. Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK, and Shi X. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun 309: 1017-1026, 2003.
46. Liu B, Andrieu-Abadie N, Levade T, Zhang P, Obeid LM, and Hannun YA. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J Biol Chem 273: 11313-11320, 1998.
47. Maeba S, Ichiyama T, Ueno Y, Makata H, Matsubara T, and Furukawa S. Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules. Ann Allergy Asthma Immunol 94: 670-674, 2005.
48. Matsuzawa A, Nishitoh H, Tobiume K, Takeda K, and Ichijo H. Physiological roles of ASK1-mediated signal transduction in oxidative stress- and endoplasmic reticulum stress-induced apoptosis: advanced findings from ASK1 knockout mice. Antioxid Redox Signal 4: 415-425, 2002.
49. Maxwell PH. HIF-1's relationship to oxygen: simple yet sophisticated. Cell Cycle 3: 156-159, 2004.
50. Nakamura H, Yoshimura K, McElvaney NG, and Crystal RG. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest 89: 1478-1484, 1992.
51. Nakamura T, Nakamura H, Hoshino T, Ueda S, Wada H, and Yodoi J. Redox regulation of lung inflammation by thioredoxin. Antioxid Redox Signal 7: 60-71, 2005.
52. Nordberg J and Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system, free Radic Biol Med 31: 1287-1312, 2001.
53. O'Reilly MA. Redox activation of p21Cip1/WAF1/Sdi1: a multifunctional regulator of cell survival and death. Antioxid Redox Signal 7: 108-118, 2005.
54. Okamoto H, Iwamoto T, Kotake S, Momohara S, Yamanaka H, and Kamatani N. Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis. Clin Exp Rheumatol 23: 323-330, 2005.
55. Pande V and Ramos MJ. NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors. Curr Med Chem 12: 357-374, 2005.
56. Parola M, Bellomo G, Robino G, Barrera G, and Dianzani MU. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxid Redox Signal 1: 255-284, 1999.
57. Pizzi M, Sarnico I, Boroni F, Benetti A, Benarese M, and Spano PF. Inhibition of IkappaBalpha phosphorylation prevents glutamate-induced NF-kappaB activation and neuronal cell death. Acta Neurochir Suppl 93: 59-63, 2005.
58. Poole LB, Karplus PA, and Claiborne A. Protein sulfenic acids in redox signaling. Annu Rev Pharmacol Toxicol 44: 325-347, 2004.
59. Pourazar J, Mudway IS, Samet JM, Helleday R, Blomberg A, Wilson SJ, Frew AJ, Kelly FJ, and Sandstrom T. Diesel exhaust activates redox sensitive transcription factors and kinases in human airways. Am J Physiol Lung Cell Mol Physiol 289: L724-L730, 2005.
60. Puxeddu I, Lack G, Smith SJ, and Levi-Schaffer F. Reduced eosinophil pro-fibrogenic effect in severe childhood asthma compared to mild disease: an effect of corticosteroids? Pediatr Pulmonol 38: 222-228, 2004.
61. Rahman I. Inflammation and the regulation of glutathione level in lung epithelial cells. Antioxid Redox Signal 1: 425-447, 1999.
62. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol 36: 95-109, 2003.
63. Rahman I. Oxidative stress, transcription factors and chromatin remodeling in lung inflammation. Biochem Pharmacol 64: 935-942, 2002.
64. Rahman I. Redox signaling in the lungs. Antioxid Redox Signal 7: 1-5, 2005.
65. Rahman I. Regulation of glutathione in inflammation and chronic lung diseases. Mutat Res 579: 58-80, 2005.
66. Rahman I, Biswas SK, Jimenez LA, Torres M, and Forman HJ. Glutathione, stress responses, and redox signaling in lung inflammation. Antioxid Redox Signal 7: 42-59, 2005.
67. Rahman I, Gilmour PS, Jimenez LA, Biswas SK, Antonicelli F, and Aruoma OI. Ergothioneine inhibits oxidative stress- and TNF-alpha-induced NF-kappa B activation and interleukin-8 release in alveolar epithelial cells. Biochem Biophys Res Commun 302: 860-864, 2003.
68. Rahman I and MacNee W. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am J Physiol 277: L1067-L1088, 1999.
69. Rahman I, van Schadewijk AA, Crowther AJ, Hiemstra PS, Stolk J, MacNee W, and De Boer WI. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166: 490-495, 2002.
70. Rangasamy T, Guo J, Mitzner WA, Roman J, Singh A, Fryer AD, Yamamoto M, Kensler TW, Tuder RM, Georas SN, and Biswal S. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med 202: 47-59, 2005.
71. Reynaert NL, Ckless K, Wouters EF, van der Vliet A, and Janssen-Heininger YM. Nitric oxide and redox signaling in allergic airway inflammation. Antioxid Redox Signal 7: 129-143, 2005.
72. Ryter SW and Choi AM. Heme oxygenase-1: redox regulation of a stress protein in lung and cell culture models. Antioxid Redox Signal 7: 80-91, 2005.
73. Sadidi M, Geddes TJ, and Kuhn DM. S-thiolation of tyrosine hydroxylase by reactive nitrogen species in the presence of cysteine or glutathione. Antioxid Redox Signal 7: 863-869, 2005.
74. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17: 2596-2606, 1998.
75. Shibanuma M, Mori K, Kim-Kaneyama JR, and Nose K. Involvement of FAK and PTP-PEST in the regulation of redox-sensitive nuclear-cytoplasmic shuttling of a LIM protein, Hic-5. Antioxid Redox Signal 7: 335-347, 2005.
76. Shrivastava A and Aggarwal BB. Antioxidants differentially regulate activation of nuclear factor-kappa B, activator protein-1, c-jun amino-terminal kinases, and apoptosis induced by tumor necrosis factor: evidence that JNK and NF-kappa B activation are not linked to apoptosis. Antioxid Redox Signal 1: 181-191, 1999.
77. 2-induced proliferation of primary alveolar epithelial cells is mediated by MAP kinases. Antioxid Redox Signal 7: 6-13, 2005.
78. Stamler JS and Hausladen A. Oxidative modifications in nitrosative stress. Nat Struct Biol 5: 247-249, 1998.
79. Tchilibon S, Zhang J, Yang Q, Eidelman O, Kim H, Caohuy H, Jacobson KA, Pollard BS, and Pollard HB. Amphiphilic pyridinium salts block TNF alpha/NF kappa B signaling and constitutive hypersecretion of interleukin-8 (IL-8) from cystic fibrosis lung epithelial cells. Biochem Pharmacol 70: 381-393, 2005.
80. Thomas JA, Poland B, and Honzatko R. Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation. Arch Biochem Biophys 319: 1-9, 1995.
81. Tsoumakidou M, Tzanakis N, Chrysofakis G, and Siafakas NM. Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD. Chest 127: 1911-1918, 2005.
82. Usatyuk PV, Vepa S, Watkins T, He D, Parinandi NL, and Natarajan V. Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells. Antioxid Redox Signal 5: 723-730, 2003.
83. Valacchi G, Pagnin E, Phung A, Nardini M, Schock BC, Cross CE, and van der Vliet A. Inhibition of NFkappaB activation and IL-8 expression in human bronchial epithelial cells by acrolein. Antioxid Redox Signal 1: 25-31, 2005.
84. Vega MI, Jazirehi AR, Huerta-Yepez S, and Bonavida B. Rituximab-induced inhibition of YY1 and Bc1-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappaB activity: role of YY1 and Bc1-xL in Fas resistance and chemoresistance, respectively. J Immunol 175: 2174-2183, 2005.
85. Wisnewski AV, Liu Q, Liu J, and Redlich CA. Glutathione protects human airway proteins and epithelial cells from isocyanates. Clin Exp Allergy 35: 352-357, 2005.
86. Woo HA, Chae HZ, Hwang SC, Yang KS, Kang SW, Kim K, and Rhee SG. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 300: 653-656, 2003.
87. Woo JH, Lim JH, Kim YH, Suh SI, Min do S, Chang JS, Lee YH, Park JW, and Kwon TK. Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 23: 1845-1853, 2004.
88. Yu GL, Wei EQ, Zhang SH, Xu HM, Chu LS, Zhang WP, Zhang Q, Chen Z, Mei RH, and Zhao MH. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. Pharmacology 73: 31-40, 2005.
89. Yu YY, Li Q, and Zhu ZG. NF-kappaB as a molecular target in adjuvant therapy of gastrointestinal carcinomas. Eur J Surg Oncol 31: 386-392, 2005.